Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Cisco Systems stock: Income investors buy the dip: https://www.marketbeat.com/logos/articles/med_20240215120254_chart-csco-2152024ver001.png
Cisco Systems stock: Income investors buy the dip

Cisco Systems (NASDAQ: CSCO) issued a decent FQ2 report but guided lower for Q3, leaving the market less than inspired. However cold the guide, someone is stepping into the buy the dip, and it

Cisco Systems stock: Income investors buy the dip: https://www.marketbeat.com/logos/articles/med_20240215120254_chart-csco-2152024ver001.png
Cisco Systems stock: Income investors buy the dip

Cisco Systems (NASDAQ: CSCO) issued a decent FQ2 report but guided lower for Q3, leaving the market less than inspired. However cold the guide, someone is stepping into the buy the dip, and it

Cisco Systems stock: Income investors buy the dip: https://www.marketbeat.com/logos/articles/med_20240215120254_chart-csco-2152024ver001.png
Cisco Systems stock: Income investors buy the dip

Cisco Systems (NASDAQ: CSCO) issued a decent FQ2 report but guided lower for Q3, leaving the market less than inspired. However cold the guide, someone is stepping into the buy the dip, and it

Arista Networks stock soars past big tech rival Cisco: https://www.marketbeat.com/logos/articles/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg
Arista Networks stock soars past big tech rival Cisco

Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.

Arista posted

Arista Networks stock soars past big tech rival Cisco: https://www.marketbeat.com/logos/articles/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg
Arista Networks stock soars past big tech rival Cisco

Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.

Arista posted

Arista Networks stock soars past big tech rival Cisco: https://www.marketbeat.com/logos/articles/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg
Arista Networks stock soars past big tech rival Cisco

Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.

Arista posted

Arista Networks stock soars past big tech rival Cisco: https://www.marketbeat.com/logos/articles/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg
Arista Networks stock soars past big tech rival Cisco

Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.

Arista posted

Bitcoin's soaring rally lifts several crypto-stocks: https://www.marketbeat.com/logos/articles/med_20240215183624_bitcoins-soaring-rally-lifts-several-crypto-stocks.jpg
Bitcoin's soaring rally lifts several crypto-stocks

After the launch of close to a dozen Bitcoin spot ETFs proved to be a sell-the-news event for the popular cryptocurrency, the price of Bitcoin has recovered and surged to a two-year high.

Bitcoin

Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73623/AC-160224.001.png
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73623/AC-160224.001.png
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73623/AC-160224.001.png
Occidental Petroleum stock price is ready to gush higher: https://www.marketbeat.com/logos/articles/med_20240215093116_chart-oxy-2152024ver001.png
Occidental Petroleum stock price is ready to gush higher

The Occidental Petroleum (NYSE: OXY) investment thesis has been getting more bullish over the last two years, setting the stock up for a substantial rally. Q4 results aside, the market appears

Impinj stock surges on strong earnings and guidance: https://www.marketbeat.com/logos/articles/med_20240212130941_impinj-stock-surges-on-strong-earnings-and-guidanc.jpg
Impinj stock surges on strong earnings and guidance

If you check a bag while flying on Delta Air Lines Inc. (NYSE: DAL), it may be tracked using technology from Impinj Inc. (NASDAQ: PI).

Impinj stock traded lower on February 12, getting support

Grid Dynamics und Yieldmo implementieren eine ML-Plattform der nächsten Generation, um die Markteinführung neuer ML-Modelle zu beschleunigen und die Leistung für Werbetreibende zu verbessern: https://www.irw-press.at/prcom/images/messages/2024/73611/GridDynamics_150224_DEPRCOM.001.png
Grid Dynamics und Yieldmo implementieren eine ML-Plattform der nächsten Generation, um die Markteinführung neuer ML-Modelle zu beschleunigen und die Leistung für Werbetreibende zu verbessern

Wichtigste Punkte:

 

-          Grid Dynamics und sein Kunde Yieldmo haben gemeinsam eine fortschrittliche ML-Plattform mit einem umfassenden Toolset entwickelt, das dazu beiträgt,

Pfizer at 10-year support: Is it a massive buy opportunity?: https://www.marketbeat.com/logos/articles/med_20240212102305_pfizers-at-10-year-support-is-it-a-massive-buy-opp.jpg
Pfizer at 10-year support: Is it a massive buy opportunity?

For shareholders of the multinational biotech giant Pfizer Inc. (NYSE: PFE), it might feel like the stock's all-time highs set during the pandemic were centuries ago. After making its

Pfizer at 10-year support: Is it a massive buy opportunity?: https://www.marketbeat.com/logos/articles/med_20240212102305_pfizers-at-10-year-support-is-it-a-massive-buy-opp.jpg
Pfizer at 10-year support: Is it a massive buy opportunity?

For shareholders of the multinational biotech giant Pfizer Inc. (NYSE: PFE), it might feel like the stock's all-time highs set during the pandemic were centuries ago. After making its

Restaurant Brands expands its Burger King franchise empire: https://www.marketbeat.com/logos/articles/med_20240212111728_restaurant-brands-expands-its-burger-king-franchis.jpg
Restaurant Brands expands its Burger King franchise empire

Quick-service restaurant company Restaurant Brands Inc. (NYSE: QSR) owns four well-known fast food brands, including Tim Hortons, Burger King, Popeyes Louisiana Kitchen and Firehouse Subs. 

The

Restaurant Brands expands its Burger King franchise empire: https://www.marketbeat.com/logos/articles/med_20240212111728_restaurant-brands-expands-its-burger-king-franchis.jpg
Restaurant Brands expands its Burger King franchise empire

Quick-service restaurant company Restaurant Brands Inc. (NYSE: QSR) owns four well-known fast food brands, including Tim Hortons, Burger King, Popeyes Louisiana Kitchen and Firehouse Subs. 

The

Gene therapy: Why does it cost millions for a single treatment?: https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg
Gene therapy: Why does it cost millions for a single treatment?

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the 

Gene therapy: Why does it cost millions for a single treatment?: https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg
Gene therapy: Why does it cost millions for a single treatment?

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the 

Gene therapy: Why does it cost millions for a single treatment?: https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg
Gene therapy: Why does it cost millions for a single treatment?

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the 

How to use options calendar spreads to generate weekly income: https://www.marketbeat.com/logos/articles/med_20240214084820_option-cal-intc.jpg
How to use options calendar spreads to generate weekly income

There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a

How to use options calendar spreads to generate weekly income: https://www.marketbeat.com/logos/articles/med_20240214084820_option-cal-intc.jpg
How to use options calendar spreads to generate weekly income

There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a

How to use options calendar spreads to generate weekly income: https://www.marketbeat.com/logos/articles/med_20240214084820_option-cal-intc.jpg
How to use options calendar spreads to generate weekly income

There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a

How to use options calendar spreads to generate weekly income: https://www.marketbeat.com/logos/articles/med_20240214084820_option-cal-intc.jpg
How to use options calendar spreads to generate weekly income

There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a